Read the Official PANTHERx Press Release. PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive …
This past year has proven to be one of record patient satisfaction scores for PANTHERx Rare. In the first half of 2021, PANTHERx led the independent specialty pharmacy category of …
Read the Official PANTHERx Press Release. PANTHERx Rare has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “The results of the Managed Markets …
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as a limited distribution partner for new drug TAVNEOS (avacopan). TAVNEOS, an orally …
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the second quarter …
PANTHERx Rare is excited to announce that it has earned URAC’s Rare Disease Center of Excellence Designation. This distinction, given only to pharmacies that establish the high level of skill …
Read the Official PANTHERx Press Release. PANTHERx Rare announced today that it was selected by Mitsubishi Tanabe Pharma America, Inc. (MTPA) as the exclusive U.S. pharmacy distribution partner for EXSERVAN™ (riluzole). …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announced today that it was selected by Rhythm Pharmaceuticals as the exclusive U.S. pharmacy distribution partner for IMCIVREE™ (setmelanotide). The drug was …
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the first quarter …
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the fourth quarter …
